Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
77 hedge funds and large institutions have $42.4M invested in Genesis Healthcare, Inc. in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 9 closing their positions.
37% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 19
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
0% more funds holding
Funds holding: 77 → 77 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $49.5M → $42.4M (-$7.02M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.7M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$766K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$709K |
| 4 |
Renaissance Technologies
New York
|
+$392K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$209K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
-$1.44M |
| 2 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$913K |
| 3 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$886K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$521K |
| 5 |
Morgan Stanley
New York
|
-$219K |
GEN Hedge Fund Activity: Q2 2019 in Review
77 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2019, worth a combined $42.4M — down 14% from $49.5M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GEN positions and 9 closed out — a net gain of 2 holders — while 26 added to existing stakes and 19 trimmed.
The largest buyer was BlackRock, adding an estimated $1.7M. The largest seller was Glassman Wealth Services, exiting entirely with an estimated $1.44M sold.
- 77 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $42.4M of Genesis Healthcare, Inc. stock for Q2 2019, down 14% quarter-over-quarter.
- 11 funds opened new Genesis Healthcare, Inc. positions in Q2 2019 and 9 closed out, a net change of +2 holders.
- The largest Genesis Healthcare, Inc. buyer in Q2 2019 was BlackRock, an estimated $1.7M added.
- The largest Genesis Healthcare, Inc. seller in Q2 2019 was Glassman Wealth Services, an estimated $1.44M sold.
Based on aggregated 13F filings for Q2 2019.